Basic Viagra Professional Information

• INN (International Nonproprietary Name): Sildenafil (often as sildenafil citrate in clinical formulations).
• Brand Names Available In Canada (English): Viagra (Pfizer) and Novo-Sildenafil (Teva Canada); packaging commonly in 2, 4, 8 tablet packs.
• ATC Code: G04BE03 (Drugs used in erectile dysfunction: phosphodiesterase type 5 inhibitors).
• Forms & Dosages: Film-coated tablets 25 mg, 50 mg, 100 mg; Revatio oral suspension 10 mg/mL for pulmonary arterial hypertension; injections used in hospital settings (2.5 mg/mL, 10 mg/12.5 mL).
• Manufacturers In Canada (English): Pfizer and Teva Canada (Novo-Sildenafil).
• Registration Status In Canada (English): Approved for erectile dysfunction; generics available after patent decisions enabled market entry.
• OTC / Rx Classification: Prescription-only in Canada (no OTC Viagra Connect equivalent in Canada).

Latest Research Highlights (Canada & International)

Patients ask: “How recent is the evidence for sildenafil and does it apply to Canada?”

Regulatory and product-data summaries in the supplied source do not list specific 2022–2025 randomized controlled trial results for Canada, so country‑specific cohort studies are not specified in the available data.

Global evidence historically supports sildenafil's efficacy for erectile dysfunction, and multiple generics and brand formulations are approved in many jurisdictions according to the product dossier.

The supplied data notes that “Viagra Professional” is a marketing term used by some e‑shops to suggest faster action for 100 mg sildenafil, but it is not an officially recognised regulatory brand.

Comparative meta‑analyses across PDE5 inhibitors are referenced conceptually in the industry literature, though no specific meta‑analysis details from 2022–2025 are provided in the raw data.

Rapid‑release or other reformulations are described in the market as claiming faster onset, but the raw dataset does not contain head‑to‑head trial metrics comparing 100 mg vs lower doses or rapid‑release formulations.

Where to place a table: Insert a table of key studies (Author, Year, Country, N, Primary Endpoint, Result, Relevance To Canada) in the editorial layout for clinicians to review.

Include a data‑highlight callout box for safety signals where you summarise priapism frequency and cardiovascular event reporting from pharmacovigilance datasets.

Patient‑centred note: The raw data does not specify Indigenous or rural enrolment in trials; highlight the need for inclusive recruitment and reporting.

• Top Five Study Takeaways (place as bullets in the article): efficacy consistent across brands; onset typically 30–60 minutes; duration ~4–5 hours; 100 mg is maximum single dose; “Viagra Professional” is a marketing term, not a regulatory product.

• Definition List Suggestion: Rapid‑Release Sildenafil = market term for reformulations claiming faster absorption; Standard Film‑Coated Sildenafil = licensed 25/50/100 mg tablet formulations as listed in product monographs.

Clinical Effectiveness In Canada

Many readers wonder: “Does sildenafil work as expected when I buy it in Canada?”

Sildenafil (INN) is available in Canada as Pfizer's Viagra and as generics such as Novo‑Sildenafil following patent changes that allowed generics to enter the market.

Health Canada approvals and product labels support sildenafil for erectile dysfunction and a different formulation, Revatio, for pulmonary arterial hypertension.

Effectiveness metrics used in practice and trials focus on erection rigidity, duration, and patient‑reported outcomes; these endpoints are the basis for clinical counselling.

The product information in the dataset states average onset is about 30–60 minutes with an effect that can last up to approximately 4–5 hours.

Clinicians should check the Drug Identification Number (DIN) on the package to confirm authenticity and can perform a DIN lookup if unsure about a product.

Insert a small table (product name, DIN example, manufacturer, typical pack sizes) in editorial copy for quick reference at the point of care.

• Monitoring Outcomes: blood pressure checks, inquiry about vision changes, and documentation of erection duration to screen for priapism.

Patient considerations: counsel on realistic expectations, involve partners if appropriate, and ensure bilingual labelling (EN/FR) where required by provincial regulations.

Indications & Expanded Uses

Common question: “What is sildenafil approved for in Canada and what uses are off‑label?”

Approved indications in Canada include erectile dysfunction for film‑coated tablets and pulmonary arterial hypertension for the Revatio oral suspension formulation.

Standard approved dosing for ED is as‑needed dosing, typically starting at 50 mg about one hour before activity with flexibility to increase to 100 mg or decrease to 25 mg; Revatio is dosed at 10 mg/mL oral suspension or 20 mg three times daily depending on the formulation and indication.

Off‑label uses reported in practice include female sexual dysfunction, altitude sickness, and Raynaud phenomenon, but the raw dataset characterises these as limited, mixed or investigational evidence.

• Definition List Suggestion: Approved Indication = use authorised by Health Canada; Off‑Label Use = clinically used outside the approved label without regulatory approval; Investigational Use = being studied in trials.

• Common Off‑Label Scenarios: female sexual dysfunction (evidence mixed), altitude illness (limited support), Raynaud phenomenon (small studies only), and certain vascular conditions (investigational).

Insert a table mapping Indication → Typical Dose → Evidence Strength to support clinician discussions.

Patient advice: obtain informed consent for off‑label use, document discussions in the chart, and warn that provincial drug plans (e.g., ODB, BC PharmaCare, RAMQ) commonly do not cover ED treatment and may not reimburse off‑label prescriptions.

Cultural expectation: many Canadians expect clear regulatory backing, so clinicians should discuss risks and benefits in English and French as appropriate.

Composition & Brand Landscape

People often ask: “Is ‘Viagra Professional’ a different drug from Viagra or generic sildenafil?”

The active ingredient is sildenafil citrate (INN) in standard clinical formulations.

Common tablet presentations in Canada are 25 mg, 50 mg and 100 mg film‑coated tablets, while Revatio is sold as a 10 mg/mL oral suspension for pulmonary hypertension.

Canadian brand availability includes Viagra (Pfizer) and Canadian generics such as Novo‑Sildenafil produced by Teva Canada following post‑2013 patent changes that allowed generics to enter the market.

“Viagra Professional” appears in online marketing as a descriptor usually for 100 mg tablets claiming faster action, but the raw data clearly states it is not a regulatory recognised brand.

• Major Canadian Manufacturers: Pfizer and Teva Canada.
• Common International Generic Suppliers: Teva, Mylan, Sandoz, Zentiva, Cipla, Ajanta, Ranbaxy.

Insert a table mapping brands, strengths, pack sizes and placeholder DINs for editorial use.

Patient‑centric notes: Canadian packaging generally requires bilingual labelling (EN/FR), pharmacies should inspect the DIN to confirm authenticity, and older adults may require lower starting doses indicated on labels.

Contraindications & Special Precautions

Many users want to know: “When should I not take sildenafil?”

Absolute contraindications listed in the product information include concurrent nitrates, prior severe allergic reaction to sildenafil, recent myocardial infarction or stroke, unstable angina, severe hypotension, and hereditary retinitis pigmentosa.

Relative contraindications include severe hepatic or renal impairment, predisposition to priapism (for example sickle cell disease), active peptic ulcer, and anatomical penile deformity.

• Immediate Red Flags: dizziness, chest pain, sudden vision loss, and erection lasting longer than four hours (priapism).

Insert a data‑highlight box for high‑risk subgroups such as elderly patients over 65, those with cardiovascular disease, and Indigenous populations with higher cardiometabolic disease prevalence—these groups need careful cardiovascular risk assessment before prescribing.

Pharmacists working in community chains should routinely screen for nitrate prescriptions and review provincial drug profiles before dispensing.

Dosage Guidelines (Canadian Context)

Common real‑world question: “What dose should I start with and what adjustments are needed?”

For erectile dysfunction the usual starting dose is 50 mg taken about one hour before sexual activity, with the option to increase to 100 mg or reduce to 25 mg based on efficacy and tolerability.

The maximum recommended single dose per day is 100 mg.

For pulmonary arterial hypertension, Revatio formulations are used at 10 mg/mL oral suspension or 20 mg three times daily depending on the specific prescribing information.

Elderly patients over 65 generally start at 25 mg due to increased sensitivity and pharmacokinetic changes.

Liver and kidney impairment require dose reductions or caution; severe impairment may contraindicate use or necessitate specialist oversight.

• Patient Advice: take on an empty stomach when possible for faster onset; high‑fat meals can delay onset; avoid excessive alcohol.

Provincial nuances: ED treatment is often not routinely covered by ODB, BC PharmaCare, or RAMQ, and some provinces allow pharmacist‑led assessments or prescribing in community settings to improve access.

Interactions Overview

Key patient worry: “Will sildenafil interact with my other medicines?”

The most dangerous interaction is with nitrates, which can cause severe hypotension and is an absolute contraindication to co‑administration.

Potent CYP3A4 inhibitors such as ritonavir or ketoconazole increase sildenafil exposure and may require dose reduction or avoidance.

Alpha‑blockers increase the risk of orthostatic hypotension when combined with sildenafil and require starting at low doses and close monitoring.

Recreational nitrates (“poppers”) are also a serious interaction risk and should be explicitly asked about during screening.

Large grapefruit intake may increase sildenafil levels, and high‑fat meals delay onset of action.

Health Canada interaction warnings should be communicated during counselling and documented in the provincial electronic drug profile where available.

• Patient Tip: disclose all prescription, OTC and online purchases (including products labelled “Viagra Professional”) to your pharmacist.

Cultural Perceptions & Patient Habits

Patients often worry about privacy, stigma and cost when seeking ED treatment in Canada.

Canadians generally prefer regulated care through the health system and expect clear labelling and bilingual information on medicines.

Online patient forums and local community groups show trends toward discreet pharmacy pickup, telehealth prescribing, and interest in lower‑cost generics.

Rural patients may rely more on mail order or cross‑border pharmacies, while urban residents have easier access to in‑person pharmacist consultations.

Indigenous populations face additional barriers to accessing sexual health services and benefit from culturally safe, community‑based counselling.

• Common Patient Behaviours: online purchase, hesitancy to discuss sexual health in person, involving partners in treatment decisions.

Data highlight: cross‑border shopping to the United States for lower prices occurs, but importing medicines carries safety and regulatory risks; consumers should verify DINs and source legitimacy.

Availability & Pricing Patterns In Canada

Practical question: “Where can I buy sildenafil in Canada and how much will it cost?”

Sildenafil is prescription‑only in Canada and available as Viagra (Pfizer) and generics including Novo‑Sildenafil from Teva Canada in typical pack sizes of 2, 4, or 8 tablets.

Retail availability includes community pharmacy chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, plus licensed online Canadian pharmacies.

Insert an editorial table comparing list prices across major chains and online pharmacies, showing typical generic savings and cross‑border price differentials to the U.S.

Provincial plan coverage: erectile dysfunction treatments are rarely covered by ODB, BC PharmaCare or RAMQ for routine ED, but PAH formulations may be covered under specific criteria.

• Buying Cautions: verify the DIN on packaging, avoid unregulated e‑shops selling products labelled “Viagra Professional”, and prefer regulated Canadian pharmacies for safety.

In our online pharmacy, viagra professional is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Many Canadians balance privacy, safety and cost and choose established chains for counselling and authentication of product DINs.

Comparable Medicines And Preferences

Patients ask: “Which PDE5 inhibitor is right for me?”

Sildenafil is one of several PDE5 inhibitors available in Canada, alongside tadalafil (Cialis), vardenafil (Levitra) and avanafil (Spedra).

Key comparative points: sildenafil onset is typically 30–60 minutes with duration around 4–5 hours, tadalafil has a much longer duration up to 36 hours, and avanafil is marketed for faster onset.

Pros and cons checklist: choose tadalafil for a long window, sildenafil for cost and established generics, and avanafil for speed if available and tolerated.

Formulary decisions and DIN availability in Canada influence prescribing and patient cost; generics often offer a cost advantage where coverage is limited.

FAQ

• Can I Get Sildenafil Without A Prescription In Canada? — No; sildenafil is prescription‑only in Canada and requires a prescriber or pharmacist assessment, unlike the UK’s Viagra Connect model.
• Is “Viagra Professional” Legitimate? — “Viagra Professional” is a marketing term used by some online sellers and is not an officially recognised Health Canada brand; always verify the DIN and source.
• Will Provincial Drug Plans Cover Sildenafil? — Provincial plans rarely cover sildenafil for erectile dysfunction; PAH formulations may be covered under specific criteria through ODB/PharmaCare/RAMQ.
• What If I’m On Nitrates? — Concurrent use with nitrates is an absolute contraindication; seek emergency care if nitrates and sildenafil are taken together and report to your prescriber immediately.

Patient‑safety tip: keep packaging and the DIN handy for pharmacy verification, insurance claims and any adverse event reporting.

Guidelines For Proper Use (Pharmacist & Clinician Advice)

Clinicians and pharmacists want concise, practical guidance for safe prescribing and dispensing.

Verify the indication on the prescription and confirm the product’s DIN and manufacturer before dispensing.

Screen for nitrates and major drug interactions, including potent CYP3A4 inhibitors and alpha‑blockers.

Start lower doses in seniors and patients with hepatic or renal impairment and counsel on timing relative to meals and alcohol.

Warn patients about counterfeit imports labelled “Viagra Professional” and advise purchasing only from regulated pharmacies.

• Workflow Tools: use a checklist (drug history, cardiovascular risk, partner involvement), an EN/FR counselling script, and an off‑label consent template when applicable.

Community pharmacists in national chains can provide discreet counselling, complete nitrate screening and liaise with provincial drug plans for prior authorizations when needed.

Emphasise culturally safe care for Indigenous patients and offer telepharmacy or mail order options for rural clients while ensuring privacy and DIN verification.

Delivery Across Canada (English)